tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of David Evans, 1 are a BUY (100%).
Analyst David Evans, currently employed at KEPLER CHEUVREUX, carries an average stock price target met ratio of 100% that have a potential upside of 36.3% achieved within 477 days.
David Evans’s has documented 2 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on NVS, Novartis AG ADR at 07-Sep-2022.
Analyst best performing recommendations are on NVS (NOVARTIS AG ADR).
The best stock recommendation documented was for NVS (NOVARTIS AG ADR) at 9/7/2022. The price target of $92.78 was fulfilled within 477 days with a profit of $24.71 (36.3%) receiving and performance score of 0.76.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell Since 10-Sep-2026
$136
$-15.12 (-10.01%)
1 months 17 days ago
(10-Sep-2026)
1/2 (50%)
$-1.48 (-1.08%)
171
Buy Since 26-Mar-2026
$170
$14.59 (9.39%)
7 months 1 days ago
(26-Mar-2026)
10/11 (90.91%)
$20.3 (13.56%)
569
Hold Since 11-Mar-2026
$180
$33.97 (23.26%)
$105
7 months 16 days ago
(11-Mar-2026)
1/2 (50%)
$24.2 (15.53%)
1814
Hold Since 07-Oct-2024
$180
$28.88 (19.11%)
$125
8 months 10 days ago
(17-Feb-2026)
7/8 (87.5%)
$18.74 (11.62%)
1318
Buy Since 11-Sep-2024
$130
8 months 26 days ago
(31-Jan-2026)
2/2 (100%)
$22.14 (20.53%)
548
What Year was the first public recommendation made by David Evans?
